Survival analysis showed that TERTp mutation was a predictor of better prognosis in IDH‐mutant grade 2 gliomas, while poor OS was associated with all Grade 4 gliomas and all IDH‐wildtype histology grade 2 or 3 gliomas. The gene discussed is IDH2; the disease is central nervous system cancer.